John Burnett

8.2k total citations · 1 hit paper
150 papers, 6.4k citations indexed

About

John Burnett is a scholar working on Building and Construction, Molecular Biology and Virology. According to data from OpenAlex, John Burnett has authored 150 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Building and Construction, 33 papers in Molecular Biology and 18 papers in Virology. Recurrent topics in John Burnett's work include Building Energy and Comfort Optimization (37 papers), Sustainable Building Design and Assessment (21 papers) and HIV Research and Treatment (18 papers). John Burnett is often cited by papers focused on Building Energy and Comfort Optimization (37 papers), Sustainable Building Design and Assessment (21 papers) and HIV Research and Treatment (18 papers). John Burnett collaborates with scholars based in Hong Kong, United States and United Kingdom. John Burnett's co-authors include John J. Rossi, W.L. Lee, Shiming Deng, Hongxing Yang, Lin Lu, F.W.H. Yik, David V. Schaffer, Adam P. Arkin, Katrin Tiemann and Jiehua Zhou and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

John Burnett

147 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RNA-Based Therapeutics: Current Progress and Future Prospects

2012 720 citations John Burnett, John J. Rossi Chemistry & Biology profile →

Peers

Countries citing papers authored by John Burnett

Since Specialization

Citations

This map shows the geographic impact of John Burnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Burnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Burnett more than expected).

Fields of papers citing papers by John Burnett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Burnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Burnett. The network helps show where John Burnett may publish in the future.

Co-authorship network of co-authors of John Burnett

This figure shows the co-authorship network connecting the top 25 collaborators of John Burnett. A scholar is included among the top collaborators of John Burnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Burnett. John Burnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CRISPR-Cas9-mediated gene disruption of HIV-1 co-receptors confers broad resistance to infection in human T cells and humanized mice 2022 ·Molecular Therapy — Methods & Clinical Development ·Shasha Li, (unknown), John Burnett	20
2	Exosome-mediated stable epigenetic repression of HIV-1 2021 ·Nature Communications ·(unknown), Roslyn M. Ray, (unknown), (unknown), Nicole Grepo, Tristan Scott, John Burnett, Kevin V. Morris	61
3	Identification of a therapeutic interfering particle—A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance 2021 ·Cell ·Sonali Chaturvedi, Gustavo Vasen, (unknown), Xinyue Chen, Nathan Beutler, (unknown), (unknown), (unknown), (unknown), John Burnett, (unknown), Peiyi Chen, Blaise Ndjamen, Mélanie Ott, (unknown), Thomas F. Rogers, Davey M. Smith, Leor S. Weinberger	44
4	CRED9: a differentially expressed elncRNA regulates expression of transcription factor CEBPA 2021 ·RNA ·Ryan L. Setten, Pritsana Chomchan, (unknown), John Burnett, John J. Rossi	8
5	Nucleolar Localization of HIV-1 Rev Is Required, Yet Insufficient for Production of Infectious Viral Particles 2018 ·AIDS Research and Human Retroviruses ·(unknown), Mayumí Takáhashi, John Burnett, Dominique L. Ouellet, Haitang Li, John J. Rossi	7
6	Listeria monocytogenes is Prevalent in Retail Grocery Produce Environments, but Salmonella enterica is Rare 2017 ·John Burnett	1
7	High throughput sequencing analysis of RNA libraries reveals the influences of initial library and PCR methods on SELEX efficiency 2016 ·Scientific Reports ·Mayumí Takáhashi, Xiwei Wu, Michelle Ho, Pritsana Chomchan, John J. Rossi, John Burnett, Jiehua Zhou	77
8	Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID “Meet the Experts” 2015 Workshop Summary 2015 ·AIDS Research and Human Retroviruses ·Ramesh Akkina, Atef Allam, Alejandro B. Balazs, Joel N. Blankson, John Burnett, Sofía Casares, J. Víctor García, Kim J. Hasenkrug, Fatah Kashanchi, Scott G. Kitchen, Florian Klein, Priti Kumar, Andrew D. Luster, Larisa Y. Poluektova, Mangala Rao, Brigitte E. Sanders-Beer, Leonard D. Shultz, Jerome A. Zack	52
9	Mutual Information Analysis Reveals Coevolving Residues in Tat That Compensate for Two Distinct Functions in HIV-1 Gene Expression 2012 ·Journal of Biological Chemistry ·Siddharth S. Dey, Yuhua Xue, Marcin P. Joachimiak, Gregory D. Friedland, John Burnett, Qiang Zhou, Adam P. Arkin, David V. Schaffer	9
10	RNA-Based Therapeutics: Current Progress and Future Prospects breakdown → 2012 ·Chemistry & Biology ·John Burnett, John J. Rossi	720
11	Combinatorial Latency Reactivation for HIV-1 Subtypes and Variants 2010 ·Journal of Virology ·John Burnett, Kwang‐il Lim, (unknown), John J. Rossi, David V. Schaffer, Adam P. Arkin	91
12	HIV Promoter Integration Site Primarily Modulates Transcriptional Burst Size Rather Than Frequency 2010 ·PLoS Computational Biology ·(unknown), John Burnett, Jonathan E. Foley, David V. Schaffer, Adam P. Arkin	86
13	HIV Evades RNA Interference Directed at TAR by an Indirect Compensatory Mechanism 2008 ·Cell Host & Microbe ·Joshua N. Leonard, Priya S. Shah, John Burnett, David V. Schaffer	35
14	Gene transfer of a novel vasoactive natriuretic peptide stimulates cGMP and lowers blood pressure in mice 2004 ·American Journal of Physiology-Heart and Circulatory Physiology ·Shuchong Pan, Rajiv Gulati, Cheryl S. Mueske, Tyra A. Witt, Amir Lerman, John Burnett, Robert D. Simari	5
15	Role of the natriuretic peptides in the cardiorenal and humoral actions of omapatrilat: Insights from experimental heart failure 2001 ·Current Hypertension Reports ·(unknown), Alessandro Cataliotti, John Burnett	4
16	Use of a portable indoor environmental quality logger for indoor environmental quality assessment 1999 ·ASHRAE winter conference papers ·Dixon Chan, John Burnett, (unknown)	3
17	ELF magnetic fields from nonarmouredmulti-core powercables 1999 ·IEE Proceedings - Science Measurement and Technology ·Yaping Du, John Burnett	2
18	Large-scale survey of thermal comfort in office premises in Hong Kong 1998 ·ASHRAE winter conference papers ·(unknown), John Burnett, Richard de Dear, (unknown)	40
19	Integrating radiant/operative temperature controls into building energy simulations 1998 ·ASHRAE winter conference papers ·Jianlei Niu, John Burnett	23
20	Remodeling and reparation of the cardiovascular system 1992 ·Journal of the American College of Cardiology ·(unknown), Piero Anversa, Paul W. Armstrong, Christian G. Brilla, John Burnett, J. M. Cruickshank, R DEVEREUX, Thomas D. Giles, Niels Korsgaard, Carl V. Leier, Frederick A.O. Mendelsohn, W. Motz, Michael J. Mulvany, Bodo E. Strauer	255

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact